Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Guangdong Dahuanong Animal Health Buys Majority Stake in Competitor

publication date: Jan 9, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Guangdong Dahuanong Animal Health Products will purchase a 60% stake in Foshan Standard Bio-tech Co., Ltd., a fellow veterinary products company, paying 158 million RMB ($25.4 million). Dahuanong said the acquisition would add products to its portfolio, especially a chicken coccidiosis vaccine. Foshan Standard makes pharmaceutical preparations and feed additives, as does Dahuanong. More details....

Stock Symbol: (SHE: 300186)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors